Litcius/Paper detail

SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study

Hossein Poustchi, Maryam Darvishian, Zahra Mohammadi, Amaneh Shayanrad, Alireza Delavari, Ayad Bahadorimonfared, Saeid Eslami, Shaghayegh Haghjooy Javanmard, Ebrahim Shakiba, Mohammad Hossein Somi, Amir Emami, Nader Saki, Ahmad Hormati, Alireza Ansari‐Moghaddam, Majid Saeedi, Fatemeh Ghasemi‐Kebria, Iraj Mohebbi, Fariborz Mansour-Ghanaei, Manoochehr Karami, Hamid Sharifi, Farhad Pourfarzi, Nasrollah Veisi, Reza Ghadimi, Sareh Eghtesad, Ahmadreza Niavarani, Ali Asgari, Anahita Sadeghı, Majid Sorouri, Amir Anushiravani, Mohammad Amani, Soudeh Kaveh, Akbar Feizesani, Payam Tabarsi, Hossein Keyvani, Melineh Markarian, Fatemeh Shafighian, Ali Reza Sima, Alireza Sadjadi, Amir Reza Radmard, Ali H. Mokdad, Maryam Sharafkhah, Reza Malekzadeh

2020The Lancet Infectious Diseases175 citationsDOIOpen Access PDF

Topics & Concepts

SeroprevalenceMedicinePopulationCross-sectional studyDemographyPandemicEnvironmental healthCoronavirus disease 2019 (COVID-19)ImmunologySerologyAntibodyInternal medicineDiseaseInfectious disease (medical specialty)SociologyPathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDermatological and COVID-19 studies
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study | Litcius